Company Filing History:
1 out of 38 
1 out of 6 
1 out of 8 Years Active: 2019
Title: Piotr Konieczny: Innovator in Myotonic Dystrophy Treatment
Introduction
Piotr Konieczny is a notable inventor based in València, Spain. He has made significant contributions to the field of medical research, particularly in the treatment of myotonic dystrophy. His innovative work has led to the development of a unique compound aimed at addressing this challenging condition.
Latest Patents
Konieczny holds a patent for "Compounds for the treatment of myotonic dystrophy." This invention relates to a compound of formula (I), which is not caffeine, intended for use in treating myotonic dystrophy types 1 and 2. The patent also encompasses compositions that include this compound and introduces new compounds that are dimers of the original formula.
Career Highlights
Throughout his career, Piotr Konieczny has worked with esteemed institutions such as Universitat de València and Institut Químic de Sarria CETS Fundació Privada. His research has focused on developing therapeutic solutions that can significantly improve the quality of life for individuals affected by myotonic dystrophy.
Collaborations
Konieczny has collaborated with notable colleagues, including Ruben Artero Allepuz and Josep Castells Boliart. These partnerships have fostered a collaborative environment that enhances the research and development of innovative treatments.
Conclusion
Piotr Konieczny's contributions to the treatment of myotonic dystrophy exemplify the impact of innovative research in medicine. His work continues to inspire advancements in therapeutic solutions for complex health issues.